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GENOME-WIDE ASSOCIATION STUDY OF SUICIDE DEATH AND POLYGENIC PREDICTION OF 
CLINICAL ANTECEDENTS
ABSTRACT
Objective: Suicide death is a highly preventable, yet growing, worldwide health crisis. To date, there has 
been a lack of adequately powered genomic studies of suicide, with no sizable suicide death cohorts 
available for study. To address this limitation, we conducted the first comprehensive genomic analysis of 
suicide death using previously unpublished genotype data from a large, population-ascertained cohort.
Methods: The analysis sample consisted of 3,413 population-ascertained cases of European ancestry 
and 14,810 ancestrally matched controls. Analytical methods included principal components analysis for 
ancestral matching and adjusting for population stratification, linear mixed model genome-wide 
association testing (conditional on genetic relatedness matrix), gene and gene set enrichment testing, 
polygenic score analyses, as well as SNP heritability and genetic correlation estimation using LD score 
regression.
Results: GWAS identified two genome-wide significant loci (6 SNPs, p<5x10–8, including rs34399104, 
rs35518298, rs34053895, rs66828456, rs35502061, and rs35256367). Gene-based analyses implicated 
22 genes on chromosomes 13, 15, 16, 17, and 19 (q<0.05). Suicide death heritability was estimated at 
h2SNP = .25 (SE = .04), and .16 (.02) when converted to a liability scale. Notably, suicide polygenic scores 
were significantly predictive. Polygenic scores for several other psychiatric disorders and psychological 
traits were also predictive, particularly behavioral disinhibition and major depressive disorder. 
Conclusions: In this report, we identify multiple genome-wide significant loci/genes and demonstrate 
polygenic score prediction of suicide death case-control status, adjusting for ancestry, in independent 
training and test sets. Additionally, we report that suicide death cases have increased genetic risk for 
behavioral disinhibition, major depression, depressive symptoms, autism spectrum disorder, psychosis, 
and alcohol use disorder relative to controls. 
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INTRODUCTION
Suicide death is a behavioral event which reflects a complex, heritable phenotype with diverse clinical 
antecedents and environmental risk factors.1 The estimated annual age-adjusted suicide death 
prevalence rate is approximately 0.014% in the United States,2 and this rate has been steadily 
increasing since 2000.3 Suicide is now ranked the second leading cause of death for all persons 15-24 
years old in the United States.4 As such, suicide is currently considered a major public health challenge,5 
which has spurred research into its etiology and clinical prediction.6,7 
While it is established that suicide is significantly heritable,8 well-powered genomic research on 
the topic has been largely limited to the study of suicide-related behaviors rather than the ultimate 
phenotype of suicide death. And though results from well-powered GWAS of suicidal behavior have 
advanced our understanding of the process,9 the vast majority of suicidal behavior does not result in 
suicide death.1,10 Thus, suicidal behavior represents a less severe and likely more heterogeneous 
phenotype than suicide death, characteristics which may adversely affect statistical power to detect 
genetic associations. Conversely, the unambiguous phenotype of suicide death avoids several confounds 
inherent in the study of suicidal behavior or ideation, and also focuses study on one of the single most 
critical contemporary public health outcomes. Previous genomic studies of suicidal behavior have also 
been limited by narrow ascertainment, studying only individuals with specific diagnoses (e.g., mood 
disorders, psychotic disorders) in order to maximize severity and accommodate post hoc study designs. 
We avoid this limitation here, instead using population-based sampling with ascertainment wholly 
independent of any co-occurring diagnoses; thus improving the representativeness of cases to the 
corresponding population and, consequently, the generalizability of results. 
Suicide death, like its associated clinical antecedents including schizophrenia and depression, 
has a highly multifactorial, and likely highly polygenic, etiology.9,11 Currently, the scientific literature lacks 
well-powered studies of suicide death in relation to molecular genetic risk for any medical or psychiatric 
diagnoses, and no robust polygenic scores have yet been developed for the critical outcome of suicide 
death. There have been, however, a few modestly powered GWAS of suicide death published,12,13 the 
largest of which combined two independent Japanese cohorts totaling 746 completed suicide cases.13 
Further, a recent UK Biobank GWAS of suicidal behavior has conducted preliminary polygenic analyses 
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of suicide death using a very modest number completed suicide cases (n = 127).14 Of note, these smaller 
studies reported evidence of polygenicity in both suicidal behavior and suicide death, but with widely 
varying SNP-based heritability estimates, from h2SNP = 4.615 and 7.6%14 for suicidal behavior not including 
death, to h2SNP = 35-48% for suicide death.13 The current study marks a notable advance from earlier 
research, as it uses the world’s largest DNA databank of suicide death, merged with a massive bank of 
electronic medical record and sociodemographic data,16,17 to comprehensively model common variant 
genetic, and clinical phenotypic, precursors of suicide death.
This study adds to the growing body of genomic research on suicide,13,14 providing the first 
adequately powered genome-wide association study of suicide death. Analyses integrated data on modes 
of suicide death, medical and psychiatric diagnostic (ICD-10) codes,18 and medical and psychiatric 
polygenic scores to comprehensively model common variant genetic risk for suicide death. Secondary 
analyses of sex differences were conducted due to the substantial sex differences in suicide death rates 
and modes of suicide death.19,20 Reliable and significant prediction of case-control status was achieved, 
adjusting for ancestry, using both (1) a novel polygenic score for suicide death and (2) polygenic scores 
for a range of comorbid psychiatric and medical risk factors, particularly behavioral disinhibition, major 
depressive disorder, and depressive symptoms. Additionally, gene set enrichment, SNP heritability, and 
genetic correlations were examined in this unique, unpublished data resource. We conclude with a brief 
discussion of the relevance of our findings to the broader field and promising future research directions.
METHODS
Sample Ascertainment
Cases
In collaboration with the centralized, statewide Utah Office of Medical Examiner (OME), the authors 
obtained DNA samples from ~6000 persons who died by suicide. The centralized OME and conservative 
determination helped to maximize the accuracy of suicide case status.21 Suicide cause-of-death 
determination results from a detailed investigation of the scene of the death and circumstances of death, 
determination of medical conditions by full autopsy, review of medical and other public records 
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concerning the case, interviews with survivors, and standard toxicology workups. Suicide determination is 
traditionally made quite conservatively due to its impact on surviving relatives. 
DNA from suicide deaths were extracted from whole blood using the Qiagen Autopure LS 
automated DNA extractor (www.qiagen.com). Genotyping is described below. Data collection and 
genotyping for the Utah Suicide Study is ongoing. To date, 4,381 samples have been genotyped in two 
waves as determined by the date of sample receipt and the availability of genotyping funds (for detailed 
information on sample collection see Supplementary Methods S1. After quality control procedures and 
ancestry analysis, data are comprised of 3,413 Utah suicide deaths. The Utah population is primarily 
Northwestern European in ancestry, a relatively genetically homogeneous group with low inbreeding 
across generations, comparable to the rest of the United States.22 
Controls
Generation Scotland. Controls closely matching the Northern European ancestry of the cases were 
obtained from previously curated datasets in the UK. Wave 1 analysis included 3,623 founder controls 
from the population-based Generation Scotland Scottish Family Health Study.23 The Generation Scotland 
Scottish Family Health Study (N > 24,000) constitutes an ancestrally comparable population-based cohort 
for comparison with the suicide decedents in Utah. To eliminate confounding arising from intra-dataset 
relatedness, only the 3,623 founders from the Generation Scotland dataset were used in analyses.
UK10K.  A total of 11,049 UK10K controls24 were analyzed in wave 2 and GWAS analyses of 
both waves. This second control cohort is comprised of approximately 4000 genomes from the UK along 
with 6000 exomes from UK individuals with selected health phenotypes. We chose these data due to the 
extensive phenotyping and characterization of any medical conditions present, and to avoid choosing a 
cohort of entirely psychiatrically and medically healthy individuals. 4,000 highly phenotyped “super 
control” samples were supplied from the TwinsUK study from King’s College London and the Avon 
Longitudinal Study of Parents and Children. UK10K was a collaborative project to examine obesity, 
autism, schizophrenia, familial hypercholesterolemia, thyroid disorders, learning disabilities, ciliopathies, 
congenital heart disease, coloboma, neuromuscular disorders, and rare disorders including severe insulin 
resistance. Analyses of this control cohort included all diagnostic groups. While this inclusion may have 
Page 6 of 25The American Journal of Psychiatry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Peer Review Only
been conservative due to possible associations of chronic disease with suicide risk, determination of 
effects of specific disease states was beyond the scope of the current study. Genotyping and sequencing 
procedures for UK10K have been previously described24 (http://www.uk10k.org) and all molecular genetic 
data from UK10K were filtered to the hard call variants present in our suicide death cohort prior to 
imputation of all cohorts simultaneously. 
1000 Genomes Reference Panel. The CEU population from the 1000 Genomes Project25 (1KG), 
which includes only Utah residents carefully screened for Northwestern European ancestry, was utilized 
as a model for excluding ancestrally discordant suicide and control samples. These CEU data were 
downloaded from the 1000 Genomes Project public repository. Unrelated individuals in the CEU provide a 
compelling, albeit small, ancestrally matched control resource (n = 99). A variety of candidate control 
samples were assessed via PCA for ancestral comparability to CEU and decedent data, with UK10K and 
Generation Scotland founder data representing the closest match.
Utah controls would be an ideal match for the suicide cases, but as with many GWAS, local 
controls were not readily available at the sample size needed for GWAS. CEPH ancestry 1KG were a 
useful comparison group to assess the likelihood that UK controls were an appropriate match for the 
cases. In addition (and described in more detail below), we performed a Generation Scotland control-
UK10K control GWAS and subsequently eliminated any SNPs from the case-control analysis that 
evidenced signal between the control cohorts. This was performed to minimize the possibility of false 
positives in the case control GWAS due to population and geographic stratification across cohorts.
Genotyping and Quality Control
Suicide cases were genotyped using Illumina Infinium PsychArray platform measuring 593,260 single 
nucleotide polymorphisms (SNPs). Generation Scotland samples were genotyped using Illumina 
OmniExpress SNP GWAS and exome chip, measuring 700,000 and 250,000 SNPs, respectively.23 
UK10K samples were whole genome sequenced24 and variants were extracted to match the available 
QC’d hard-called variants in the suicide cases. Genotypes were subsequently imputed in all cases and 
controls (details of imputation are presented in Analytics, below). Both case and control datasets resulted 
from population-based ascertainment. Cryptic relatedness was modeled via the derivation of genomic 
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relatedness matrices. Genotyping quality control was performed using SNP clustering in 
Illumina Genome Studio https://www.illumina.com/techniques/microarrays/array-data-analysis-
experimentaldesign/genomestudio.html). SNPs were retained if the GenTrain score was > 0.5 and the 
Cluster separation score was > 0.4. SNPs were converted to HG19 plus strand. SNPs with >5% missing 
genotypes were removed. Samples with a call rate < 95% were removed.
Prior to case-control GWAS, a control-control GWAS was conducted (using the same methods 
described in Data Analysis: Genome-Wide Association Testing, below) in order to detect differences 
between control groups (all variants both pre- and post-imputation with GWAS control-control q values 
<.10). For example, chromosome 4 TLR variants are often filtered from analyses involving Scottish 
controls due to population stratification. 167 variants in the control-control comparison were then filtered 
from subsequent case-control analyses. For the purposes of future meta-GWAS analyses and because 
the MHC is relevant to psychiatric risk, we included MHC-associated filtered variants in a second version 
of summary statistics.
Data Analysis
Principal Component Analysis (PCA)
Supplementary Figure S1 shows 1000 Genomes superpopulations and suicide case/control samples, 
both included and excluded, plotted by the top two principal components (PCs). Approximately 20% of the 
population-based suicide cases had a significant degree of non-Northwestern European ancestry (chiefly 
of admixed ancestry) and were excluded from analyses. The variation explained by top four PCs was 
reduced 7.2-fold. The top four PCs explain 0.89% of variation before sample filtering and 0.12% of 
variation after filtering if calculated on pruned genotypes. For adequate statistical power, we examined 
only cases of Northern European ancestry. However, it is clear from Figure S1 (a) and (c) that the cohort 
was comprised of multiple ancestries and that research on suicide death in non-European ancestries will 
reflect an important step beyond this first study.
PCA was performed on control, suicide, and 1000 Genomes cohorts after linkage disequilibrium 
(LD) pruning at a 0.2 threshold. To exclude ancestrally heterogeneous samples, the top four principal 
components (defined as those components which accounted for > 0.1% of the genotype variance) were 
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used to establish PC centroid limits centered around 1000 Genomes CEU data such that 99% of the CEU 
data fell within the limits. Only suicide and control samples also falling within these limits were considered 
ancestrally homogenous and were included in the association study. The ancestry PCA was performed 
using RaMWAS, a Bioconductor package written by our analytical team, which comprises a complete 
toolset for high dimensional genomic analyses.26,27  
Imputation
European ancestry cases and controls were well-matched to 1000 Genomes CEPH. The Haplotype 
Reference Consortium is comprised in part by UK controls used here so we elected to impute genotypes 
based on the 1000 Genomes reference panel using minimac328 and Eagle.29 SNPs were imputed jointly 
from a common SNP list based on variant overlap across case and control datasets. SNPs with 
ambiguous strand orientation, >5% missing calls, or Hardy-Weinberg equilibrium p < 0.001 were 
excluded. SNPs with minor allele frequency below 0.01 or imputation R2 < 0.5 or average imputation call 
rate < 0.9 were excluded after imputation. Genomic data were handled using PLINK.30,31 Final GWAS 
analysis was performed on 7,519,308 variants passing quality control.
Genome-wide Association Testing
A Linear Mixed Model (LMM) algorithm tested variant association with suicide death and provided follow-
up examination of significant hits for linkage disequilibrium and gene set enrichment. GWAS were 
performed using GEMMA,32 a computationally efficient and open-source LMM algorithm for GWAS that 
models population stratification remaining after PCA by use of genomic relatedness matrices. Sex was 
not included as a covariate in GWAS analyses due to the association of suicide with sex status at a ratio 
of approximately 4:1 males to females. GWAS with hard call-only and then with imputed data were 
examined separately to assess potential population stratification unique to our imputed GWAS. Prior to 
case-control GWAS, control-control GWAS was implemented to filter signal likely due to population 
stratification in the controls. To assess the likelihood that observed results may be due to chance, we 
assessed FDR at 5%. 
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Gene and Gene Set Enrichment and Functional Mapping
SNP results from the GWAS were then mapped to genes within 1kb of the SNP. These genes were 
examined for gene set enrichment and LD using FUMA33 and GREAT.34 FUMA annotates SNPs, uses 
MAGMA to identify associated genes (of approximately 18,612), and provides gene and gene pathway 
enrichment analysis (of approximately 10,649 pathways). GREAT analyzes the functional significance of 
sets of cis-regulatory regions by modeling the genome regulatory landscape using multiple information 
sources and can determine the functional domain of intergenic variants. GREAT improves upon the 
identification of genes associated with non-coding genomic regions through statistically rigorous 
incorporation of more distal binding sites from 20 ontologies. The GWAS catalog 
(https://www.ebi.ac.uk/gwas/) includes studies and associations if they: include a primary GWAS analysis 
from >100,000 SNPs with SNP-trait p-value <1.0x10-5 in the overall (initial GWAS + replication) 
population. The most significant SNP from each independent locus is extracted.
Polygenic Risk Scores, SNP Heritability (h2), and Genetic Correlations (rG)
Discovery GWAS summary statistics for phenotypes were compiled to score each cohort for polygenic 
risk. A polygenic score (PS) for suicide death was derived using PRSice 2.035 and summary statistics 
from a 10-fold cross validation procedure to avoid overfitting. To elaborate, k-folds cross-validation is a 
well-established method36 allowing a single dataset to serve as both training and testing data for the 
purpose of suicide death polygenic score development and validation. We conservatively set the p-value 
threshold for predicting case status based on the data to 1.0. This eliminated overfitting arising from 
choosing the threshold based on the phenotype. 
Using related methods, we calculated polygenic scores for several psychiatric and psychological 
traits in the current dataset. Of several thousand medical and psychological GWAS now available as 
training weights for calculating polygenic scores, only GWAS with N>10,000 individuals and >1,000 cases 
(or for population-based studies, adequate base rates) were selected for these analyses. These generally 
included the largest medical and psychiatric GWAS. When multiple versions of GWAS were available for 
the same phenotype (for example, neuroticism or depression), we selected the most comprehensive (see 
the online GWAS Atlas at http://atlas.ctglab.nl/). PRSice 2.0 was used to calculate individual PS for 59 
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phenotypes with estimated risk allele effect sizes for each discovery sample trait. A PS is traditionally 
calculated as a weighted sum score, where a score for an individual in the target sample is calculated by 
the summation of each SNP multiplied by the effect size of that SNP in the discovery GWAS. Based on 
the cross-disorder psychiatric genomics findings to date, we hypothesized significant positive prediction of 
suicide with PS for depressive symptoms, depressive disorders, behavioral disinhibition, schizophrenia, 
autism, loneliness, child IQ, alcohol use, and neuroticism. 
Linkage Disequilibrium SCore regression (LDSC)37,38  was used to calculate the observed scale 
common variant h2 using summary statistics from a logistic regression model with five ancestry covariates 
and pruning related samples at 0.05 p̂ from IBD. LDSC was also used to calculate common variant 
molecular genetic correlations (rG) with psychiatric and medical phenotypes. Finally, we performed 
secondary analyses to characterize genetic predictors and clinical antecedents of suicide (Supplementary 
Methods S2) and mode of suicide death (Supplementary Methods S3). Specifically, in these secondary 
analyses, we conducted (1) epidemiological association tests between four sufficiently prevalent/powered 
modes of death (i.e., gun, overdose, asphyxiation, and violent trauma) and 30 ICD-10 derived clinical 
antecedents, and (2) association tests the suicide polygenic score with modes of death, adjusting for five 
ancestry covariates in multivariate regressions. 
Sex Differences
As suicide rates and modes of suicide death are characterized by substantial sex differences,19,20 we 
performed secondary epidemiological and genomic analyses to characterize sex differences in mode of 
death and clinical antecedents. These sex stratified analyses mirrored the full sample analyses described 
above, including (1) sex-stratified epidemiological association tests between four sufficiently 
prevalent/powered modes of death (i.e., gun, overdose, asphyxiation, and violent trauma) and 30 ICD-10 
derived clinical antecedents, and (2) sex stratified association tests the suicide polygenic score with 
modes of death, adjusting for five ancestry covariates in multivariate regressions. We constrained these 
exploratory analyses to only those medical diagnoses with frequencies high enough in either females or 
males to provide decent power for testing and report false discovery rate (FDR) corrected p-values; 
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nonetheless, it is worth noting that power for these secondary analyses of sex differences was limited by 
N, which was restricted to cases-only and stratified by sex and mode of death. 
RESULTS
Genome-wide Association: Positional Evidence
A total of six variants from two loci met genome-wide criteria for statistical association with suicide death 
(p < 5x10-8). An additional 52 variants were nominally significant at q < 0.1 and mapped to 22 genes (λ = 
1.015, Figure 1 and Table 1).39,40 All results on the full cohort are derived from analyses adjusting for 
effects of ancestry. Genes associated with top genomic regions are presented in Supplementary Table 
S1. The significant chromosome 13 and 15 regions were supported by additional positive results that 
were suggestive but below threshold. The large number of signals in the SNP-based tests prompted 
quality control analyses varying the degree of LD pruning prior to PCA for the purposes of sensitivity 
analysis. Results and respective λ’s were consistent across these analyses. Supplementary Figures S2-
S8 present additional plots of the top signals in each of eight regions. 
Gene-based Results and Pathway Functional Enrichment Tests
Mapping top positional SNP hits to genes suggested 22 gene associations, including chromosome 13 
genes, Daschund family transcription factor 1 (DACH1), Ubiquitin-protein ligase protein (UBE3A), and 
Kelch-like family member 1 (KLHL1) on chromosome 15 (Supplementary Table S1). Gene-based analysis 
using MAGMA (FUMA1) identified an additional ten genes significantly associated (q < 0.1) with suicide 
death (Figure 2; Supplementary Table S1). GO pathway results included enrichment of histone 
modification sites SETD6, COPR5, GATAD2A. Full gene and Gene Ontology (GO, 
http://www.geneontology.org/) pathway enrichment results are presented in Supplementary Tables S2-
S3. Genes showing psychiatric associations are in green (Supplementary Table S2). 
In addition to functional pathways, FUMA analyses indicated significant enrichment for 
schizophrenia (p = 1x10-11) and bipolar disorder (p = 1x10-17) in the GWAS Catalog 
(https://www.ebi.ac.uk/gwas/; Table S1). IW-scoring in SNP-Nexus41 suggested regulatory functional 
significance for one SNP (chr13:71553748:C/T). Ten of the implicated genes from positional or gene-
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based testing have evidenced genome-wide significant differential gene expression in postmortem brain 
analyses in schizophrenia, autism, or bipolar disorder (FDR<0.1; PsychENCODE Consortium, 
Supplementary Table S4).42
Polygenic Scores, SNP Heritability, and Genetic Correlations 
In European ancestry training and test samples comprising independent case and control cohorts, and 
accounting for 20 ancestry covariates, suicide PS significantly predicted suicide death case status. 
Suicide waves 1 and 2 comprise 1,321 and 2,092 suicide cases, respectively, and were pruned for 
relatedness within waves prior to training and testing analyses. These case-control predictions are plotted 
across p-value thresholds in Figure 3. 
The LDSC common variant h2 estimate, based on the summary statistics from a logistic GWAS 
with five ancestry covariates and pruning to remove related samples, was 0.2463, SE = 0.0356. The h2 
estimate on the liability scale = 0.1567, SE = 0.0218 when considering the .2% reported population 
prevalence of completed suicide in Utah. λ in the model was 1.20, λ1000 = 1.04. These λs remained stable 
with follow-up testing of 20 PCs and with increased pruning. The suicide death cases differed significantly 
from the two UK control groups on PS of phenotypes relevant to suicide death. These differences were in 
the expected directions. Original discovery GWAS for all PS phenotypes were filtered to exclude any that 
used these control cohorts (Supplementary Table S5). 
Consistent with hypotheses, significant PS elevations included alcohol use, autism spectrum 
disorder, child IQ, depressive symptoms, disinhibition, major depression, loneliness, and schizophrenia. 
The largest effect sizes were observed for PS for behavioral disinhibition, major depressive disorder, and 
schizophrenia (Figure 4). LD Hub37 provided estimates of SNP-based shared genetic covariance for 
several phenotypes (Supplementary Table S6), though none of these SNP-based genetic correlations 
reached statistical significance. Additionally, we disaggregated suicide by mode of death into four 
categories (see Supplementary Methods S2): gun, overdose, asphyxiation, and violent trauma. We 
epidemiologically characterized these groups by testing associations with 30 ICD-10 derived clinical 
antecedents (Supplementary Figure S9; Supplementary Tables S7-S9). Additionally, we conducted PS 
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association testing with mode of death in all cases. No associations met multiple testing adjusted 
significance criteria (q < 0.1; Supplementary Figure S10; Supplementary Tables S10-S12).
Sex Differences
Epidemiological analyses of sex differences in electronic health records data indicated that suicide cases 
of both sexes evidenced clinical diagnostic clusters of 1) internalizing-trauma-cluster B psychiatric 
disorders and 2) metabolic-cardiovascular-obesity medical disorders (Supplementary Tables S13-
S18). Female cases were observed to have a higher overall number of diagnoses relative to males, which 
could reflect increased severity in females, decreased severity in males, decreased likelihood of males 
receiving diagnosis, and/or decreased help-seeking in males. This is broadly consistent with observed 
higher relative prevalence rates of gun-related death in males and overdose death in females. All 
associations of ICD and PS with mode of death are presented for females and males separately in 
Supplementary Figures S11-S14. All PS analyses include ancestry covariates. All corresponding statistics 
are reported in Supplementary Tables S19-S24. No sex-stratified polygenic scores findings met multiple 
testing adjusted significance criteria (q < 0.1).   
DISCUSSION
Results from this analysis, the first adequately powered comprehensive genomic study of suicide death, 
yield several insights and suggest important applications for future extension. The GWAS of suicide death 
identified two genome-wide significant loci on chromosomes 13 and 15. The significant SNP-based 
heritability estimate of suicide death in this GWAS (25%, or 16% on the liability scale) is greater than 
those previously reported for suicide ideation/attempt (5%)14,15 and attempt within psychiatric diagnosis 
(3-10%)43 and is closer to previous estimates reported for suicide death (35-48%).13 Fully half of the 
genes implicated by our results overlap with schizophrenia results from the GWAS Catalog (p = 1x10-11), 
and two of these 11 genes have prior associations with risk of suicidal behavior (HS3ST3B, NCAN; for 
relevant literature see Supplementary Table S25; allele frequencies and effect sizes by cohort in our 
study are presented in Table S26). 
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All but four of these schizophrenia-associated genes also drove a significant GWAS Catalog 
association with bipolar disorder (p=1x10-17), supporting a hypothesis of genetic liability to more non-
specific psychiatric illness. Of particular interest, the region on chromosome 19p13.11 in our study has 
evidence from the most recent, well-powered studies of both bipolar disorder44 and schizophrenia.45 In 
addition, our region on chromosome 16q21 has evidence not only from several large GWAS of 
schizophrenia, but also from a large meta-analysis of autism spectrum disorder.45-50
Genome-wide significant SNPs on chromosome 13 (Table 1) are all intergenic and vary with 
respect to combined annotation dependent depletion (CADD) score, an index for scoring the 
deleteriousness of single nucleotide variants as well as insertion/deletions variants in the human genome. 
Notably the variant with the strongest GWAS effect size, SNV rs34399104, reaches a CADD score of 
almost 20, indicating that it is in the top 1% of deleterious variants on the genome. 
Direct comparison of this GWAS with 110 effect sizes reported in previous literature12-15,43,51 
identified just one nominally significant variant in the largest GWAS of suicidal behavior,43 rs4870888, 
nearest to FER1L6 and FER1l6-AS2. Table S27 provides direct comparison of the previously reported 
effect sizes with those in this GWAS. SNV rs7989250 (chr 13) was reported in the UK Biobank GWAS for 
ordinal suicidality and reached a p <.05 threshold for replication in the Otsuka et al. suicide GWAS, but 
did not reach threshold in this GWAS (Table S27).
We were also able to cross-validate prediction of suicide death case-control status with polygenic 
scores for suicide death, accounting for population stratification. While within-case PS validation relies on 
stronger assumptions than other PS case-control comparisons, the considerable overlapping polygenic 
signal across p-value thresholds in this study (n = 3,413 deaths) is consistent with the two existing smaller 
polygenic analyses predicting suicidality. In one, suicidal behavior PRS predicted increased odds of 
suicide death with n = 127 deaths14 and in the other, a significant SNP-based genetic correlation of 
suicide death was observed between two independent cohorts (n = 746 deaths).13 
Perhaps most compellingly, suicide death was strongly associated with polygenic scores for 
multiple psychiatric and psychological traits. As noted above, these included alcohol use, autism 
spectrum disorder, child IQ, depression, disinhibition, schizophrenia, and loneliness (Figure S15 presents 
additional PRS plots). These results were consistent with expectations, as strong associations in cases 
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relative to both control cohorts were with behavioral disinhibition and major depressive disorder—
arguably the two most critical antecedents of suicide death.52 More generally, these results are consistent 
with the emerging consensus that genetic correlations across psychiatric diagnoses and traits are 
substantial.53 Future research with an even larger suicide death cohort will be needed to determine the 
ultimate cause of these PS associations with suicide death, with leading hypotheses arguing for the 
presence of a “p-factor” capturing general liability to psychopathology,54 contrasting those arguing for 
pleiotropic effects across a small set of psychiatric disorder clusters.55   
Limitations
Several limitations should be noted. First, it is possible that population stratification or platform 
confounds stemming from convenience controls could lead to false positives. To address this risk, we 
employed very conservative filters of both loci and subjects to minimize false positives. Values of 
λGC<1.05 are generally considered benign, although inflation in λGC is proportional to sample size.56 Both 
Generation Scotland and UK10k founder controls were extensively assessed for ancestral comparability 
to both 1000 Genomes Utah CEU25 and Utah European ancestry suicides, both matching extremely well. 
Incorporating two separate control cohorts (and formal analytical comparison of these cohorts to the 
corresponding 1KG populations) also allowed us to detect and filter out loci related to platform-specific 
technical artifacts, and subtle variation in population structure, prior to case-control analyses. Table S28 
presents results of tests for differences in loadings for up to 200 PCs by cohort and by case-control 
status. Before and after imputation, we excluded any and all variants generating q-values <.1 in a control-
control GWAS. Additionally, employing ancestral PC Mahalanobis (i.e., centroid) distance pruning, we 
have leveraged the fact the CEU 1KG subjects are largely ancestrally homogenous with our case 
samples to restrict our controls (and cases) to a highly ancestrally homogenous group.
It is also possible that the use of mixed healthy controls and controls with common medical 
conditions, as in UK10K, could exert a mild bias on effect estimates toward the null, which we do not view 
as highly problematic, given that the direction of the bias effectively reduces the risk of false positive 
findings. In the suicide case cohort, rates of common medical conditions are much higher than population 
base rates. However, in stratified control analyses, effect sizes specific to cases vs. UK10K were elevated 
relative to Generation Scotland, which is inconsistent with potential confounding of signal due to other 
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disorders. Furthermore, effect sizes for PS for other disorders, across 1000 p-value thresholds, were far 
greater between the cases and controls than between the control groups, wherein differences were 
negligible, and distributions of PS often overlapped. None of the implicated variants were significantly 
different in AF between control groups in the control-control GWAS. However, it should be noted that AF 
is relatively low for the top variants across all cohorts. 
Another limitation relates to electronic medical record data, in which prevalence for disorders is 
always confounded with age, and in a number of ways. For example, missing diagnosis could be more or 
less likely in a given decade during which a case was assessed. Younger ages are more likely to have 
complete electronic medical record information yet be less likely to be diagnosed with co-morbid medical 
conditions, schizophrenia, or personality disorders. 
Importantly, in this study there was insufficient diversity to examine effect sizes for non-European 
ancestries. We expect a sufficient number of cases for a Mexican-American ancestry GWAS within five 
years, and we will prioritize diverse ancestry groups in order to minimize potential health disparities 
stemming from homogeneous summary statistics.57 
 Future Directions
A recent review of suicide prediction models has indicated that positive predictive values for 
suicide attempt are quite high (.9), but positive predictive values for suicide death continue to hover near 
zero.58,59 In this study, we have discovered multiple genome-wide significant loci/genes, strong polygenic 
signal, and significantly increased genetic risks for behavioral disinhibition, major depression, depressive 
symptoms, autism spectrum disorder, psychosis, and alcohol use disorder in cases. Future modeling of 
multiple polygenic risks and phenotypic risk factors may help isolate important moderators of risk and 
improve objective risk measures of suicide death. Importantly, ethical challenges associated with 
predictive models of suicide death are significant, and must be addressed proactively across psychiatric 
and medical domains.6,60
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TABLES
Table 1. Genome-wide significant loci from GWAS of death by suicide.
Chr SNP ImputationR2 A1 A2
AF
Cases
AF
Controls OR 95% CI p value FDR
Nearest 
Gene Function CADD
13 rs34399104 0.75 T C 0.027 0.015 1.769 1.48–2.11 3.54x10-11 2.7x10-4 LINC00348 Intergenic 19.86
13 rs35518298 0.81 T C 0.024 0.014 1.726 1.43–2.07 1.92x10-9 7.2x10-3 LINC00348 Intergenic 0.33
13 rs34053895 0.81 A C 0.024 0.014 1.718 1.42–2.06 3.51x10-9 8.7x10-3 LINC00348 Intergenic 0.39
13 rs35502061 0.72 G A 0.024 0.014 1.703 1.41–2.05 5.97x10-9 .011 SOGA2P1 Intergenic 2.69
13 rs66828456 0.74 A C 0.027 0.015 1.707 1.42–2.04 8.63x10-9 .013 LINC00348 Intergenic 4.24
15 rs35256367 0.50 G A 0.023 0.014 1.605 1.43–2.07 1.10x10-8 .014 ATP10A Intronic 4.41
Note: Chr = chromosome, SNP = single nucleotide polymorphism, A1, A2 = alleles 1 (minor) and 2, AF = allele 1 frequency, OR = odds ratio, SE = standard error, 
CADD61,62 = combined annotation dependent depletion score. For scale, note that a CADD score of 20 means that a variant is among the top 1% of deleterious 
variants in the human genome. All variants presented in the table were imputed.
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FIGURES
Figure 1. GWAS Results. (a) QQ and Manhattan plots from GWAS of suicide death. Y-axes for both plots reflect observed p-values. The x-axis 
on the qq-plot is the number of significant p-values expected under H0, and the x-axis on the Manhattan plot maps each chromosome. The purple 
dashed line indicates FDR corrected nominal statistical significance, the green dotted line representing the threshold for genome-wide significance 
with Bonferroni correction. 57 SNPs met threshold for nominal significance and 6 met genome-wide significance. (b) Regional plots of genome-
wide significant loci on chromosomes 13 and 15.
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Figure 2. GWAS Gene-Based Results. FUMA gene-based test results: qq plot and Manhattan plot of >18,000 genes. Y-axes for both plots are 
identical and reflect observed p-values. The x-axis on the qq-plot is the number of significant p-values expected under H0, and the x-axis on the 
Manhattan plot maps each chromosome. The purple dashed line indicates threshold for FDR-corrected nominal statistical significance; 10 genes 
met this threshold for nominal significance. 
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Figure 3. Cross Validation of Suicide Polygenic Case-Control Prediction. Polygenic prediction of suicide death case status across two independent 
cohorts of cases and controls. Training GWAS summary statistics are used to score the test set for suicide polygenic risk. P-value thresholds are plotted 
on the x-axis from 0.1-1.0, reflecting the top 10% to 100% of the common variants from the training GWAS. Plots present model fit when a) predicting 
case-control status with wave 1 suicide vs. Generation Scotland summary statistics and b) predicting with wave 2 suicide vs. UK10K summary statistics. 
Scores are adjusted for 20 PCs. Summary data for the best fitting and 1.0 p-value threshold models are presented in Table S29.
A)  b)
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Figure 4. Notable Elevations of Psychiatric Polygenic Risk in Suicide Cases. P-value thresholds are plotted on the x-axis. Scores are adjusted for 20 PCs. 
Largest effect sizes and significance levels were observed for major depressive disorder, schizophrenia, and behavioral disinhibition. Summary data for the best 
fitting and 1.0 p-value threshold models for all eight phenotypes—also including alcohol use, autism spectrum disorder, child IQ, depressive symptoms, and 
loneliness—are presented in Table S29.
Major Depressive Disorder Schizophrenia Disinhibition
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SUPPLEMENTARY MATERIAL
Supplementary Methods
S1. International Classification of Diseases (ICD-10) Code Ascertainment
S2. Clinical Diagnostic Associations with Mode of Death
Supplementary Tables
S1. Genes Associated with Top Genomic Regions, FUMA Gene-Based Analysis
S2-S3. GREAT, GWAS Catalog, SNP Nexus Results
S4. Genome-Wide Significant Differential Gene Expression in PsychENCODE Postmortem Brain in 
Schizophrenia, Autism, or Bipolar Disorder
S5. Polygenic Score (PS) Discovery GWAS Summary Statistic Citation Table
S6. LD Hub Genetic Correlation Results
S7-9. All Case Diagnostic Antecedents (ICD) by Mode of Suicide (MD) Association Summary Statistics
S10-12. All Case PS-MD Summary Statistics
S13-18. Separate Female and Male ICD-MD Summary Statistics
S19-S24. Separate Female and Male PS-MD Summary Statistics
S25. Gene Literature (brief)
S26. Allele Frequencies and Summary Statistics for Top SNPs across Cohorts
S27. Cross-Study Comparison of Effect Sizes 
S28. Tests for Differences in up to 200 PCs by Cohort and by Case-Control Status
S29. Summary Statistics for the Best Fitting and 1.0 P-Value Threshold Models from Figures 3 & 4.
 
Supplementary Figures
S1. PCA of 1KG super-populations, cases, controls, and excluded samples
S2. Regional Plot of Chromosome 6 Region
S3. Regional Plot of Chromosome 14 Region
S4. Regional Plot of Chromosome 15 Region
S5. Regional Plot of Chromosome 16 Region
S6. Regional Plot of Chromosome 17 Region
S7. Regional Plot of Chromosome 17 Region
S8. Regional Plot of Chromosome 19 Region
S9. Diagnostic Antecedents (ICD) of Specific Mode of Suicide (MD) Plot: All Suicide Deaths
S10. PS x MD Plot: All Suicide Deaths
S11. ICD x MD Plot: Female Suicide Deaths > 25 Years of Age   
S12. ICD x MD Plot: Male Suicide Deaths > 25 Years of Age 
S13. PS X MD Plot: Female Suicide Deaths Plot
S14. PS X MD Plot: Male Suicide Deaths Plot
S15. Plots of Additional Case-Control Differences in Polygenic Risks
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